HUM-MOLGEN events: Analyze Data in Live Studies Without Unblinding or Spending Alpha

Who Should Attend?

This webinar will appeal to:

C-Suite:

CEO
CMO (Chief Medical Officer)
COO (Chief Operating Officer)
CIO (Chief Information Officer)

Executive Leadership:

S/VP of R&D
S/VP of Clinical Development
Therapeutic Area heads (e.g., oncology, neuro)
VP of Clinical Operations
VP of Clinical Data Management

Study Management:

Directors/Managers of Clinical Operations

What You Will Learn

Webinar attendees will:

Review how trial sponsors are obtaining a far clearer understanding of how a drug is performing against safety and efficacy endpoints while the study is underway, without increasing alpha-spend

Examine how unified insight into live data helped one biopharmaceutical company achieve the industry’s first-ever successful New Drug Application (NDA) in a highly challenging indication — one where dozens of other sponsors had tried and failed

Break down the myth that it is too difficult and costly to achieve a single, unified view across a study or program from all clinical and operational data sources

Speaker

http://Patrick%20Keenan,%20Prevail%20InfoWorks

Patrick Keenan, Chief Strategist, Prevail InfoWorks

As Chief Strategist for Prevail InfoWorks, Patrick Keenan draws on more than 15 years of experience in life sciences technology and operations to ensure Prevail’s innovative technology helps trial sponsors and CROs successfully meet today’s pressing clinical development and regulatory challenges. In addition to leading the company’s business and market strategy, he collaborates closely with Prevail’s existing and prospective customers to thoroughly understand their key business requirements and develop the most effective solutions.